Greek pharmaceuticals regulator temporarily bans parallel exports, stockpiling of five vaccines for children

Greece’s National Organisation for Medicines on Friday issued a temporary ban of parallel exports, stockpiling or intra-Community trade of five brands of children’s vaccines guarding against hepatitis and whooping cough, in order to ensure an adequate domestic supply.

The ban is for the vaccines marketed under the names Repevax (booster shot against diptheria, tetanus, whooping cough and polio), Engerix (hepatitis B), Hbvaxpro (hepatitis B), Havrix (hepatitis A) and Vaqta (hepatitis A).
The decision bans parallel trade and stock piling of the products and obliges all participants in the distribution chain to supply the domestic market as a priority, based on demand and prescriptions, until the temporary ban is either rescinded or amended.